NCT00120055View on ClinicalTrials.gov

Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2005

Study Completion Date

April 30, 2005

Conditions
Myopathy
Interventions
DRUG

Atorvastatin (Lipitor)

All Listed Sponsors
lead

University of Oslo School of Pharmacy

OTHER

NCT00120055 - Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity | Biotech Hunter | Biotech Hunter